However, the EGFR mutation status in that study were evaluated in lung cancer tissues, which may result in inauthentic performance due to discordance between primary lung cancer and brain metastases, which is reportedly up to 26.5% (21, 28). This evidence concerns the gene EGFR and lung carcinoma.